GC

Geoffrey Cumming

AnteoTech Limited | Non-Executive Director
Dr Cumming has over 20 years of experience in the healthcare and biotechnology market. His roles have progressed from pure research to sales and marketing roles through to Managing Director level and on the Board. Previously Managing Director of Roche Diagnostic Systems - Oceania Regional Centre, where he transformed a loss-making business to one achieving over 30% compound annual growth over a four-year period and the profitability levels in Roche's global organisation. He was also Managing Director and CEO of Biosceptre Ltd, an Australian-based biotechnology company commercialising a range of products in cancer diagnosis and treatment. He is member of the Risk Committee and Clinical Advisory Board.

Company and Role

Company
Title
Tenure
Since
ADO
AnteoTech Limited
  • Non-Executive Director
16yrs, 1mthApr 2009

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
ADO
AnteoTech Limited
16/12/24500,00027,267,7506,068,750N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
ADO
AnteoTech Limited
16/12/24
Issued
1,000,000$0.020$20,000Rights issue
ADO
AnteoTech Limited
31/05/24
Buy
1,200,000$0.025$30,000Placement
ADO
AnteoTech Limited
31/05/24
Issued
600,000$0.024$14,400Participation in share purchase plan
ADO
AnteoTech Limited
22/12/23
Expiry
1,500,000$0.034$51,000Options expired
ADO
AnteoTech Limited
14/11/23
Issued
468,750$0.027$12,656Participation in share purchase plan